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Truvada®
•The only medication approved by FDA for pre-exposure
prophylaxis of the HIV infection
•Tablets with fixed dosages of two antiretroviral compounds
for daily oral uptake: Tenofovir disoproxil fumarate (TDF) +
Emtricitabine (EMT) – reverse transcriptase inhibitors
↓ renal function
↓ bone mineral density
↑ hepatic enzymes
Objectives:  Incorporate TDF and EMT drugs in polymeric nanofibers produced by electrospinning; chosen polymers were polyoxyethilene (PEO)
and polycaprolactone (PCL).
 Characterize the nanofibers and study the in vitro release profile of the drugs.
 Evaluate the possibility of a topical administration of the loaded fibers , by rectal or genital route, for HIV infection prophylaxis.
Consequences
Method
1. Polymeric PEO solution
10 mg TDF + 7 mg EMT + 0,5 g PEO + 5,0 mL H2O
2. Parameters of electrospinning
Flow rate: 0,05 mL/h
Voltage: 20 kV
Needle: 0,3 mm
Room temperature
1. Polymeric PCL solution
10 mg TDF + 7 mg EMT + 0,5 g PCL+ 5,0 mL H2O
2. Parameters of electrospinning
Flow rate: 0,6 mL/h
Voltage: 15 kV
Needle: 0,6 mm
Room temperature
3. Characterization
SEM
XRD
ATR-FTIR
Controlled release assays in simulated vaginal fluid (VFS) 
(pH 4,2 at 37°C)
Results and Discussion
SEM ATR-FTIR
Estimated fiber diameters: 
from 200 nm to 2 μm 
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Control Release of TDF  and EMT from PEO and PCL nanofibers
In the fibers it was possible to identify the vibrations from the most important functional groups of the polymers but not of the
drugs. Why? 1. because drug content is small (1.7-2.0%);
2. because radiation penetration depth in the fibers is only around 1.7 mm.
Each measured 
spectrum, resulting 
from the release of 
both drugs from the 
polymer nanofibers, 
was simulated by considering variable and 
adjusted contributions of each drugs.
By contrast, from PCL nanofibers the
release of EMT is more efficient.
TDF is more easily released from PEO nanofibers fibers than EMT.
IN  CONCLUSION
By varying the hydrophobicity 
of the polymer, it is possible to 
tailor the drug release kinetics
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Blue and green lines in XRD of
PCL can reveal the presence of
the drugs within the fibers.
XRD
 
 
 
 
 
Crystalline structure of polymeric
nanofibers is not damaged by
encapsulation of the drugs.
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